Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244411 · ClinicalTrials.gov registry record · NA
Exercise and QUality Diet After Leukemia: The EQUAL Study
A NA study of Adult Survivors of Childhood Leukemia, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 2
- Study locations
NCT02244411 is a NA study of Adult Survivors of Childhood Leukemia that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 358 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02244411, a NA study of Adult Survivors of Childhood Leukemia, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 2
- Study locations
Study Summary
The EQUAL study has been designed for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are overweight or obese. The purpose of this study is to see if diet and exercise can help people lose weight and improve other health problems. This two year study will compare two methods of informing participants about ways to lose weight.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- BEHAVIORAL individual diet & physical activity counselor and website through Healthways at Hopkins
- BEHAVIORAL self directed weight loss
- OTHER fasting blood draw, measurement of height, weight and waist circumference, and blood pressure
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2014-09 |
| Est. Completion | 2025-07-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02244411
The ClinicalTrials.gov registry entry for NCT02244411 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult Survivors of Childhood Leukemia appearing as the primary indexed condition, and to 4 interventions - of which questionnaires is the first listed.
NCT02244411 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Tennessee.
Frequently Asked Questions
What is clinical trial NCT02244411 about?
NCT02244411 is a clinical study titled "Exercise and QUality Diet After Leukemia: The EQUAL Study". The EQUAL study has been designed for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are overweight or obese. The purpose of this study is to see if diet and exercise can help people lose weight and improve other health problems. This two year study will compare two methods of i...
What is the current status of trial NCT02244411?
This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2014-09. Estimated completion is 2025-07-16.
What conditions does trial NCT02244411 study?
This clinical trial studies the following conditions: Adult Survivors of Childhood Leukemia.
What interventions are being tested in trial NCT02244411?
The interventions under investigation include: questionnaires (BEHAVIORAL), individual diet & physical activity counselor and website through Healthways at Hopkins (BEHAVIORAL), self directed weight loss (BEHAVIORAL), fasting blood draw, measurement of height, weight and waist circumference, and blood pressure (OTHER).
Who is sponsoring clinical trial NCT02244411?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244411 being conducted?
This trial has 2 study locations across New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.